In summary, our findings elucidate a molecular mechanism wherein METTL14 facilitates lipid metabolism in NPC cells by elevating ANKRD22, establishing an aberrant regulatory loop that sustains m6A modifications in NPC cells. The gene discussed is METTL14; the disease is nasopharyngeal carcinoma.